LIVN Q1 2024 Earnings — LivaNova PLC Revenue & Financial Results | Market Cap Arena

LIVNLivaNova PLC

$3B

Q1 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$295M+12.0% YoY

Gross Profit

$207M70.3% margin

Operating Income

$16M5.5% margin

Net Income

-$42M-14.2% margin

EPS (Diluted)

$-0.78

QoQ Revenue Growth

-4.9%

Cash Flow

Operating Cash Flow

$10M

Free Cash Flow

$4M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$2.5B

Total Liabilities

$1.2B

Stockholders' Equity

$1.2B

Cash & Equivalents

$309M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$295M	$263M	+12.0%
Gross Profit	$207M	$174M	+19.1%
Operating Income	$16M	-$2M	+793.7%
Net Income	-$42M	$7M	-669.1%

Revenue Segments

Cardiopulmonary Segment

$156M54%

Neuromodulation Segment

$134M46%

Geographic Segments

UNITED STATES

$161M54%

Locations Excluding The United States And Europe

$80M27%

Europe

$54M18%